MIT Research Identifies Enzyme Target for Lung Cancer Risk Reduction

Researchers at MIT have identified an enzyme whose blockage appears to reduce the risk of lung tumor development by targeting lung inflammation. This scientific discovery significantly enhances the understanding of lung cancer mechanisms. The finding could inform future strategies for preventing the disease, offering a new avenue for therapeutic intervention.